Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Alogliptin/Lisinopril interaction

Angioedema

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Reyhanoglu G, et al. Tangled therapeutics: a case report on angioedema due to the co-administration of a DPP-4 inhibitor and ACE inhibitor. American Journal of the Medical Sciences 367 (Suppl.): S118, Feb 2024. Available from: URL: https://dx.doi.org/10.1016/S0002-9629%2824%2900257-X [abstract] Reyhanoglu G, et al. Tangled therapeutics: a case report on angioedema due to the co-administration of a DPP-4 inhibitor and ACE inhibitor. American Journal of the Medical Sciences 367 (Suppl.): S118, Feb 2024. Available from: URL: https://​dx.​doi.​org/​10.​1016/​S0002-9629%2824%2900257-X [abstract]
Metadaten
Titel
Alogliptin/Lisinopril interaction
Angioedema
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57124-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Ciclosporin

Case report

Octreotide